Briere, J.-B., Bowrin, K., Coleman, C., Fauchier, L., Levy, P., Folkerts, K., Toumi, M., Taieb, V., Millier, A. and Wu, O. (2019) Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with vitamin K antagonists in patients with non-valvular atrial fibrillation: a systematic literature review. Expert Review of Pharmacoeconomics and Outcomes Research, 19(19), pp. 27-36. (doi: 10.1080/14737167.2018.1518134) (PMID:30169975)

McArthur, K., Fan, Y., Pei, Z. and Quinn, T. (2014) Optimising outcome assessment to improve quality and efficiency of stroke trials. Expert Review of Pharmacoeconomics and Outcomes Research, 14(1), pp. 101-111. (doi: 10.1586/14737167.2014.870479)

Marshall, S., Fearon, P., Dawson, J. and Quinn, T.J. (2013) Stop the clots, but at what cost? Pharmacoeconomics of dabigatran etexilate for the prevention of stroke in subjects with atrial fibrillation: a systematic literature review. Expert Review of Pharmacoeconomics and Outcomes Research, 13(1), pp. 29-42. (doi: 10.1586/ERP.12.79)

Godman, B., Paterson, K., Malmström, R.E., Selke, G., Fagot, J.-P. and Mrak, J. (2012) Improving the managed entry of new medicines: sharing experiences across Europe. Expert Review of Pharmacoeconomics and Outcomes Research, 12(4), pp. 439-441. (doi: 10.1586/ERP.12.44)

Fearon, P. and Quinn, T.J. (2012) Making the call: is telestroke cost effective? Expert Review of Pharmacoeconomics and Outcomes Research, 12(1), pp. 15-18. (doi: 10.1586/ERP.11.97)

Quinn, T.J. (2011) Do integrated stroke services impact on the ‘cost’ of stroke? Expert Review of Pharmacoeconomics and Outcomes Research, 11(2), pp. 147-150. (doi: 10.1586/erp.11.7)

Quinn, T.J. and Dawson, J. (2009) Acute `strokenomics': efficacy and economic analyses of alteplase for acute ischemic stroke. Expert Review of Pharmacoeconomics and Outcomes Research, 9(6), pp. 513-522. (doi: 10.1586/erp.09.63)

Nelson, S.M. and Greer, I.A. (2006) Hypertensive disorders of pregnancy - prevantative, immediate and long term management. Expert Review of Pharmacoeconomics and Outcomes Research, Oct;6(5), pp. 541-554. (doi: 10.1586/14737167.6.5.541)